169
Views
4
CrossRef citations to date
0
Altmetric
Letters to the Editor

Takotsubo cardiomyopathy as a consequence of 4-fluoroamphetamine Mono-intoxication documented by toxicological analyses

, , , ORCID Icon, ORCID Icon & ORCID Icon
Pages 73-74 | Received 24 Dec 2019, Accepted 09 Apr 2020, Published online: 24 Apr 2020

References

  • Al-Abri S, Meier KH, Colby JM, et al. Cardiogenic shock after use of fluoroamphetamine confirmed with serum and urine levels. Clin Toxicol. 2014;52(10):1292–1295.
  • Hondebrink L, Nugteren-van Lonkhuyzen JJ, Rietjens SJ, et al. Fatalities, cerebral hemorrhage, and severe cardiovascular toxicity after exposure to the new psychoactive substance 4-fluoroamphetamine: a prospective cohort study. Ann Emerg Med. 2018;71(3):294–305.
  • Madias JE. Takotsubo syndrome due to 4-fluoroamphetamine. Clin Toxicol. 2015;53(2):136–136.
  • Lelievre B, Richeval C, Coulon A, et al. Case report on two-cathinones abuse: MPHP and N‑ethyl‑4′methylnorpentedrone, with a fatal outcome. Forensic Toxicol. 2020;38:243–254.
  • Begeman A, Franssen E. Lack of detection of new amphetamine-like drugs using conventional urinary immunoassays. Ther Drug Monit. 2018;40(1):135–139.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.